96 weeks of pegylated-Interferon- alpha-2 alpha plus tenofovir or placebo for the treatment of hepatitis delta: the HIDIT-2 study

Wedemeyer H., Yurdaydin C., Ernst S., Caruntu F. A. , Curescu M. G. , YALÇIN K., ...More

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 November 2013, vol.58 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 58
  • City: Washington
  • Country: Kiribati